Protect your wound with the ALLEVYN GENTLE foam dressing. The gentle foam dressing technology promotes optimum wound healing and protects sensitive skin. Ideal for chronic and acute wounds.
€79.20
(May vary by country)
Ready to ship in 1-3 working days ⁴
Protect your wound with the ALLEVYN GENTLE foam dressing. The gentle foam dressing technology promotes optimal wound healing and protects sensitive skin. Ideal for chronic and acute wounds.
A gently adhering silicone foam dressing for the management of wounds
with moderate to heavy exudate. The gentle adhesion facilitates
secondary fixation – sterile.
ALLEVYN GENTLE dressings are suitable for a wide range of acute and chronic wounds requiring secondary fixation, even on difficult-to-reach areas of the body.1,3,6 ALLEVYN GENTLE dressings have beendesigned for reliable everyday use and to meet the challenges of wound care on sensitive skin4,5 and can be worn for up to 7 days.*6-8
Features
- Suitable for sensitive skin: The dressings feature a gentle silicone contact layer tokeep the dressing gently secured during dressingchanges⁹,¹⁰ and to minimise pain and trauma to the wound during dressing changes.¹⁰,¹¹
- Versatile: A soft, four-way stretch dressing that can becut to size to suit many types of wound¹⁻³.
- High absorbency: Hydrocellular foam absorbs large amountsof exudate¹⁻⁸,¹² and can effectivelyabsorb viscous exudate¹³ whilst retaining its absorbency even under pressure.**²
- Promotes rapid healing: The triple-action technology promotes a moist wound environment, thereby supporting wound healing, granulation and epithelialisation whilst minimising the risk of maceration.1,7,8,14
Benefits
- No adhesive border
- Secondary fixation required
- With silicone wound contact layer
- Reduces trauma and pain duringdressing changes
- Soft and pliable, can be cut to size
- Dressing can remain in place for up to 7 days
- Suitable for sensitive and intact surrounding skin
*Depending on wound exudate.
**Demonstrated in laboratory tests. 1 Smith+Nephew 2019. Internal report. RD/19/083 v2. 2
Smith+Nephew 2019. Internal report. DS/19/058/R. 3 Smith+Nephew 2019. Internal report. DS/19/198/R Version 2. 4
Carter J. Paper presented at: Wounds UK; 2008; Harrogate, UK. 5 Rafter L, et al. Wounds UK 12(2): 70–78. 2016. 6 Smith+Nephew 2019. Internal report. DS/19/197/R. 7 Smith+Nephew 2019. Internal report. DS/19/191/R. 8 Smith+Nephew 2019. Internal report. DS/19/196/R Version 2. 9 Smith & Nephew 2014. Internal report. VTR/HVT079/ST965. 10 Vowden K et al. Poster presented at EWMA 2011. 11 Hurd, T, et al. Wounds UK 2009. 12 Benbow M. Br J Nurs. 2008;17 (Tissue Viability Supplement)(15):S4–S16. 13 Smith+Nephew 2019. Internal report. DS/19/054/R.14 Smith+Nephew 2019. Internal report. EO.AWM.PCS263.001.v1.
Dosage form
Foam dressing
| Piece: | 10 |
|---|